Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Sep 2.
Published in final edited form as: Angew Chem Int Ed Engl. 2009;48(19):3478–3481. doi: 10.1002/anie.200806239

Efforts Toward the Direct Experimental Characterization of Enzyme Microenvironments: Tyrosine100 in Dihydrofolate Reductase**

Dan Groff 1,, Megan C Thielges 1,, Susan Cellitti 1, Peter G Schultz 1,*, Floyd E Romesberg 1,*
PMCID: PMC3166254  NIHMSID: NIHMS146423  PMID: 19347910

The enzyme dihydrofolate reductase (DHFR), which catalyzes hydride transfer from the cofactor nicotinamide adenine dinucleotide phosphate (NADPH) to 7,8-dihydrofolate to produce tetrahydrofolate, has emerged as a paradigm for the study of enzyme catalysis.[13] It has been suggested that electrostatic complementarity between the enzyme and the transition state for hydride transfer contributes significantly to catalysis[47] and computational studies have identified a number residues that may mediate these interactions.[5, 7] One of the most important is Tyr100, which directly contacts the nicotinamide hydride donor (Fig. 1) and is thought to stabilize the developing positive charge on the cofactor in the hydride transfer transition state. However, protein dynamics have also been suggested to contribute to DHFR catalysis through the population of rare but reactive substrate conformations.[812]

Figure 1.

Figure 1

Structure of folate and NADP+ bound to DHFR (PDB ID 1rx2) with side chains of Tyr100, Ile14, and Phe31, as well as Ile5 shown. Molecular graphics images were produced using the UCSF Chimera package.[28]

Vibrational spectroscopy provides a direct and bond-specific approach to the characterization of the microenvironments and motions of molecules, but with proteins its application is limited by spectral congestion. Previous approaches to observe individual vibrations, such as those associated with the amide backbone, sulfhydryl or carboxyl side chains, or bound water molecules, have used heavy atom isotope labeling and difference Fourier transform infrared (FT IR) spectroscopy.[13, 14] In some cases, changes in the difference spectra have even been time resolved.[14, 15] However, the linewidths and frequencies of the absorptions are often difficult to deconvolute as they remain in a congested region of the spectrum, and they are even more difficult to interpret in terms of specific protein motions, due to coupling with other vibrations. As part of a program to develop general probes of protein microenvironments and dynamics, we have developed the use of carbon-deuterium (C-D) bonds as FT IR probes.[1624] C-D bonds are sensitive to their environment and may be incorporated anywhere throughout a protein. While they are weaker than the other endogenous chromophores, their detection and analysis are facilitated by their unique absorption in an otherwise transparent region (~2100 cm−1) of the protein IR spectrum.

In principle, the C-D based FT IR technique may be applied to a protein of any size. However, the available methods to site-selectively deuterate a protein are limited to synthesis or semi-synthesis unless the amino acid of interest is present at only a single position. These limitations preclude the general application of the technique to many proteins, including DHFR, unless specific residues are made unique by site directed mutagenesis. This latter approach has been applied to DHFR in a previous study wherein all but one methionine was mutagenized to leucine to allow for site-specific labeling.[23] In order to examine a residue such as Tyr100 in DHFR without the introduction of potentially perturbative mutations, we now report the use of a biosynthetic method to site-selectively incorporate a photocaged, deuterated amino acid, which after photolysis yields the site-selectively deuterated, but otherwise natural protein.

In previous work, o-nitrobenzyl O-tyrosine (ONBY), a tyrosine derivative protected with a photolabile o-nitrobenzyl group, was genetically encoded in E. coli using an orthogonal tRNACUATyr/aminoacyltRNA synthetase pair.[25, 26] This unnatural amino acid was efficiently and site-specifically incorporated into proteins in response to an amber stop codon (TAG), which may be introduced into any gene of interest at any desired position by site-directed mutagenesis. For an initial characterization of the microenvironments and dynamics of DHFR, we used this approach to incorporate (2,3,4,5-d4)Tyr into DHFR at Tyr100 and Tyr111. In contrast to Tyr100, Tyr111 is distal to the binding pocket and solvent exposed and was thus chosen to serve as a control. OBNY protected (d4)Tyr100 and (d4)Tyr111 DHFR were expressed in E. coli and purified as described in the Supporting Information. After purification, deprotection proceeded quantitatively upon exposure to 360 nm light for 10 min in 40 mM Tris buffer, pH 8.0, to afford 20 and 26 mg/L, respectively, of (d4)Tyr100 and (d4)Tyr111 DHFR, as confirmed by SDS-PAGE and ESI mass spectrometry (Supporting Information). Protected and deprotected (d4)Tyr111 DHFR showed wild-type activity, while (d4)Tyr100 DHFR showed wild-type activity only after deprotection (Supporting Information).

We first characterized the C-D absorptions of protonated and deprotonated (2,3,4,5-d4)tyrosine (Cambridge Isotopes) in 1 N HCL or 1 N NaOH, respectively. Both spectra show overlapping absorptions in the region around 2200–2300 cm−1 that were fit to two Gaussian functions and assigned to C-D stretching modes (Supporting Information). As four C-D stretching modes are expected, we conclude that either two pairs of absorption bands are too overlapped to be resolved or two bands are too low in intensity to be observed. At both low and high pH, the two absorptions have similar linewidths of ~20 cm−1; but in alkaline solution the absorptions are blue-shifted by 15 to 17 cm−1 and the relative amplitudes are shifted to favor the high frequency component.

To characterize the specific microenvironments and dynamics of DHFR, and how they might change during catalysis, we characterized the apoenzyme and the holoenzyme (bound NADPH), as well as complexes with folate and NADP+, MTX and NADPH, or with folate alone. These complexes are thought to mimic the Michaelis complex, the transition state, and the product complex, respectively.[2] Similar to the free amino acid, in each case the IR spectrum of (d4)Tyr111 DHFR showed overlapping absorptions around 2200–2300 cm−1, which again are assigned as C-D stretching modes (Table 1 and Fig. 2). The spectra are comprised of two dominant absorptions with relative frequencies and amplitudes similar to the deprotonated amino acid. However, while fitting the spectra required three Gaussian functions (Supporting Information), the frequencies and linewidths of the dominant absorptions did not change upon addition of any of the ligands.

Table 1.

Spectroscopic data

Apo NADPH folate/NADP+ MTX/NADPH folate
(d4)Tyr100[a]
νA (cm−1) 2247.0 ± 1.1 2247.4 ± 0.8 2246.0 ± 0.3 2247.0 ± 0.3 2246.7 ± 0.4
FWHMA (cm−1) 16.8 ± 2.4 14.5 ± 0.8 13.4 ± 0.9 16.0 ± 0.5 13.6 ± 0.6
νB (cm−1) 2266.6 ± 0.6 2267.6 ± 0.7 2262.6 ± 0.7 2269.0 ± 0.3 2265.7 ± 0.9
FWHM B (cm−1) 18.8 ± 0.7 14.5 ± 1.9 19.4 ± 2.2 14.1 ± 1.8 26.6 ± 0.5
νC (cm−1) 2278.9 ± 1.0
FWHM C (cm−1) 14.9 ±0.5
(d4)Tyr111[a, b]
νA (cm−1) 2253.4 ± 0.3 2253.5 ± 0.2 2253.3 ± 0.7 2252.5 ± 0.3 2253.7 ± 0.2
FWHMA (cm−1) 19.1 ±1.8 18.8 ± 0.6 21.6 ± 1.1 18.3 ± 0.7 17.6 ± 0.4
νB (cm−1) 2276.0 ± 0.8 2278.0 ± 0.8 2275.9 ± 1.9 2269.0 ± 1.9 2276.1 ± 1.9
FWHM B (cm−1) 20.6 ± 0.8 19.3 ± 1.4 21.2 ± 3.2 28.6 ± 0.4 20.7 ± 2.0
[a]

The two absorptions observed in the apo enzyme and in each complex are labeled A and B. The third absorption observed only in the folate/NADP+ complex is labeled C. ν and FHHM correspond to the center frequency and full-width at half maximum linewidth, respectively. See text for details.

[b]

The frequencies and linewidths result from fits of the dominant two absorptions.

Figure 2.

Figure 2

Spectra and fits of (d4)Tyr111 (left) and (d4)Tyr100 (right). a, f) apo DHFR, b, g) NAFPH complex, c, h) folate/NADP+ complex, d, i) MTX/NADPH complex, e, j) folate complex.

The spectra of apo, NADPH-, and MTX/NADPH-bound (d4)Tyr100 DHFR were also similar to those observed with the free amino acid, and well fit by two Gaussian functions (Table 1, dFig. 2, and Supporting Information). Only small differences were observed in the three (4)Tyr100 spectra, with each showing absorption bands around 2247 and 2267 cm−1 with linewidths of ~15 cm−1. In contrast, the (d4)Tyr100 spectra of the folate and folate/NADP+ complexes were dramatically different from the spectrum of the apo enzyme, as well as the other complexes. While the spectrum of the folate complex was well fit by two Gaussian functions at ~2247 cm−1 and ~2266 cm−1 (Supporting Information), in contrast to the other complexes, the relative amplitudes shift significantly to favor the high frequency absorption, which is also significantly broadened. The changes in amplitude resemble those induced by deprotonation of the free amino acid (see above), suggesting that Tyr100 is more strongly H-bonded in the folate complex. This is consistent with crystallographic studies which reveal an H-bond between the Tyr OH and the carbonyl backbone of Ile5 that is uniquely short in the folate complex.[2] Furthermore, we observed a correlation between the length of this H-bond in the different structures[2] and the relative intensities of the low and high frequency absorptions (Fig. 3), further supporting this interpretation.

Interestingly, three absorptions are clearly apparent in the (d4)Tyr100 spectra of the folate/NADP+ complex (Table 1, Fig. 2, and Supporting Information). Two of the absorptions, with frequencies at 2246 cm−1 and 2263 cm−1, are similar in relative amplitude, frequency, and linewidth to those observed in spectrum of the apo, NADPH-, or MTX/NADPH-bound enzymes. This suggests that in the folate/NADP+ complex Tyr100 experiences an environment that is similar to that experienced in the apo enzyme and the other complexes. However, the additional high frequency absorption at 2279 cm−1 is unique and must reflect the population of a unique microenvironment at Tyr100. Because the unique environment is not observed in the MTX/NADPH complex (where analogous ligands are bound and the protein assumes the same conformation[2]), it likely results from the charge on the cofactor. While this clearly indicates a strong electrostatic coupling between NADP+ and Tyr100, a contribution of dynamics to the population of the unique environment cannot be excluded. In fact, NMR experiments detect a significant exchange term for Tyr100 that is unique to the NADP+/folate complex, [27] supporting the idea that the unique spectrum of (d4)Tyr100 in this complex results, at least in part, from unique motions.

Structural and computational data have suggested that the hydroxyl group of Tyr100 electrostatically stabilizes the developing positive charge at C4 of the nicotinamide in the transition state. Our data clearly provide strong experimental support for this mechanism of catalysis. While the data also suggest that the dynamics of Tyr100 may change in the Michaelis complex, providing a mechanism for relaying more distal correlated motions to the reaction coordinate, thought to facilitate the population of reactive conformations, [811] additional studies are required to more directly test this idea. Nonetheless, given the tight packing between the Tyr OH and the hydride donor (the heavy atoms are separated by a distance of only 3.0 Å, Figure 1), it seems likely that the motions of Tyr100 affect not only the stability of the developing charge, but also the geometry of the reaction coordinate, and that both effects might contribute to catalysis. The C-D based technique is well suited to characterize enzyme microenvironments, including electrostatics and H-bonding, as well as dynamics, and how each may contribute to function. Finally, additional advances in the biosynthetic methodology employed here should allow for the extension of the technique to the characterization of other important residues in DHFR, and other proteins as well.

Supplementary Material

S1

Footnotes

**

This work was supported by the National Science Foundation (MCB 0346967 to F.E.R); any opinions, findings, and conclusions expressed here are those of the authors and do not necessarily reflect the views of the National Science Foundation. This work was also supported by the National Institutes of Health (PN2 EY01824 and R01 GM062159 to P.G.S.).

Supporting information for this article is available on the WWW under http://www.angewandte.org or from the author.

References

  • 1.Fierke CA, Johnson KA, Benkovic SJ. Biochemistry. 1987;26:4085–4092. doi: 10.1021/bi00387a052. [DOI] [PubMed] [Google Scholar]
  • 2.Sawaya MR, Kraut J. Biochemistry. 1997;36:586–603. doi: 10.1021/bi962337c. [DOI] [PubMed] [Google Scholar]
  • 3.Schnell JR, Dyson HJ, Wright PE. Annu Rev Biophys Biomol Struct. 2004;33:119–140. doi: 10.1146/annurev.biophys.33.110502.133613. [DOI] [PubMed] [Google Scholar]
  • 4.Cannon WR, Garrison BJ, Benkovic SJ. J Am Chem Soc. 1997;119:2386–2395. [Google Scholar]
  • 5.Garcia-Viloca M, Truhlar DG, Gao J. Biochemistry. 2003;42:13558–13575. doi: 10.1021/bi034824f. [DOI] [PubMed] [Google Scholar]
  • 6.Wong KF, WJB, Hammes-Schiffer S. J Phys Chem B. 2004;108:12231–12241. [Google Scholar]
  • 7.Greatbanks SP, Gready JE, Limaye AC, Rendell AP. J Comput Chem. 2000;21:788–811. [Google Scholar]
  • 8.Thorpe IF, Brooks CL., III J Am Chem Soc. 2005;127:12997–13006. doi: 10.1021/ja053558l. [DOI] [PubMed] [Google Scholar]
  • 9.Wang L, Goodey NM, Benkovic SJ, Kohen A. Proc Natl Acad Sci USA. 2006;103:15753–15758. doi: 10.1073/pnas.0606976103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Thorpe IF, Brooks CL., III J Phys Chem B. 2003;107:14042–14051. [Google Scholar]
  • 11.Agarwal PK, Billeter SR, Rajagopalan PT, Benkovic SJ, Hammes-Schiffer S. Proc Natl Acad Sci USA. 2002;99:2794–2799. doi: 10.1073/pnas.052005999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Boehr DD, McElheny D, Dyson HJ, Wright PE. Science. 2006;313:1638–1642. doi: 10.1126/science.1130258. [DOI] [PubMed] [Google Scholar]
  • 13.Barth A, Zscherp C. Q Rev Biophys. 2002;35:369–430. doi: 10.1017/s0033583502003815. [DOI] [PubMed] [Google Scholar]
  • 14.Garczarek F, Gerwert K. Nature. 2006;439:109–112. doi: 10.1038/nature04231. [DOI] [PubMed] [Google Scholar]
  • 15.Kötting C, Kallenbach A, Suveyzdis Y, Wittinghofer A, Gerwert K. Proc Natl Acad Sci USA. 2008;105:6260–6265. doi: 10.1073/pnas.0712095105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chin JK, Jimenez R, Romesberg FE. J Am Chem Soc. 2001;123:2426–2427. doi: 10.1021/ja0033741. [DOI] [PubMed] [Google Scholar]
  • 17.Cremeens ME, Fujisaki H, Zhang Y, Zimmermann J, Sagle LB, Matsuda S, Dawson PE, Straub JE, Romesberg FE. J Am Chem Soc. 2006;128:6028–6029. doi: 10.1021/ja061328g. [DOI] [PubMed] [Google Scholar]
  • 18.Chin JK, Jimenez R, Romesberg FE. J Am Chem Soc. 2002;124:1846–1847. doi: 10.1021/ja012312n. [DOI] [PubMed] [Google Scholar]
  • 19.Kinnaman CS, Cremeens ME, Romesberg FE, Corcelli SA. J Am Chem Soc. 2006;128:13334–13335. doi: 10.1021/ja064468z. [DOI] [PubMed] [Google Scholar]
  • 20.Sagle LB, Zimmermann J, Dawson PE, Romesberg FE. J Am Chem Soc. 2006;128:14232–14233. doi: 10.1021/ja065179d. [DOI] [PubMed] [Google Scholar]
  • 21.Sagle LB, Zimmermann J, Dawson PE, Romesberg FE. J Am Chem Soc. 2004;126:3384–3385. doi: 10.1021/ja049890z. [DOI] [PubMed] [Google Scholar]
  • 22.Sagle LB, Zimmermann J, Matsuda S, Dawson PE, Romesberg FE. J Am Chem Soc. 2006;128:7909–7915. doi: 10.1021/ja060851s. [DOI] [PubMed] [Google Scholar]
  • 23.Thielges MC, Case DA, Romesberg FE. J Am Chem Soc. 2008;130:6597–6603. doi: 10.1021/ja0779607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Weinkam P, Zimmermann J, Sagle LB, Matsuda S, Dawson PE, Wolynes PG, Romesberg FE. Biochemistry. 2008;47:13470–13480. doi: 10.1021/bi801223n. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Wang L, Brock A, Herberich B, Schultz PG. Science. 2001;292:498–500. doi: 10.1126/science.1060077. [DOI] [PubMed] [Google Scholar]
  • 26.Deiters A, Groff D, Ryu Y, Xie J, Schultz PG. Angew Chem, Int Ed. 2006;45:2728–2731. doi: 10.1002/anie.200600264. [DOI] [PubMed] [Google Scholar]
  • 27.Osborne MJ, Schnell J, Benkovic SJ, Dyson HJ, Wright PE. Biochemistry. 2001;40:9846–9859. doi: 10.1021/bi010621k. [DOI] [PubMed] [Google Scholar]
  • 28.Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. J Comput Chem. 2004;25:1605–1612. doi: 10.1002/jcc.20084. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

S1

RESOURCES